April 4, 2017 / 12:30 PM / 4 months ago

BRIEF-NantKwest and Viracta Therapeutics report series B financing

1 Min Read

April 4 (Reuters) - NantKwest Inc:

* NantKwest and Viracta Therapeutics announce series b financing and immunotherapy partnership

* NantKwest - co, Viracta Therapeutics announced initial closing of a series b preferred financing round of up to $18.4 million with co as lead investor Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below